BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15126333)

  • 1. A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin.
    Connell PP; Siddiqui N; Hoffman S; Kuang A; Khatipov EA; Weichselbaum RR; Bishop DK
    Cancer Res; 2004 May; 64(9):3002-5. PubMed ID: 15126333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells.
    Wiese C; Collins DW; Albala JS; Thompson LH; Kronenberg A; Schild D
    Nucleic Acids Res; 2002 Feb; 30(4):1001-8. PubMed ID: 11842112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells.
    Liu N; Schild D; Thelen MP; Thompson LH
    Nucleic Acids Res; 2002 Feb; 30(4):1009-15. PubMed ID: 11842113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for simultaneous protein interactions between human Rad51 paralogs.
    Schild D; Lio YC; Collins DW; Tsomondo T; Chen DJ
    J Biol Chem; 2000 Jun; 275(22):16443-9. PubMed ID: 10749867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domain mapping of the Rad51 paralog protein complexes.
    Miller KA; Sawicka D; Barsky D; Albala JS
    Nucleic Acids Res; 2004; 32(1):169-78. PubMed ID: 14704354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex formation by the human Rad51B and Rad51C DNA repair proteins and their activities in vitro.
    Lio YC; Mazin AV; Kowalczykowski SC; Chen DJ
    J Biol Chem; 2003 Jan; 278(4):2469-78. PubMed ID: 12427746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAD51C interacts with RAD51B and is central to a larger protein complex in vivo exclusive of RAD51.
    Miller KA; Yoshikawa DM; McConnell IR; Clark R; Schild D; Albala JS
    J Biol Chem; 2002 Mar; 277(10):8406-11. PubMed ID: 11744692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between human DNA repair proteins at a unique double-strand break in vivo.
    Rodrigue A; Lafrance M; Gauthier MC; McDonald D; Hendzel M; West SC; Jasin M; Masson JY
    EMBO J; 2006 Jan; 25(1):222-31. PubMed ID: 16395335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of RAD51C and XRCC3 in genetic recombination and DNA repair.
    Liu Y; Tarsounas M; O'regan P; West SC
    J Biol Chem; 2007 Jan; 282(3):1973-9. PubMed ID: 17114795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homologous recombination-deficient mutation cluster in tumor suppressor
    Prakash R; Rawal Y; Sullivan MR; Grundy MK; Bret H; Mihalevic MJ; Rein HL; Baird JM; Darrah K; Zhang F; Wang R; Traina TA; Radke MR; Kaufmann SH; Swisher EM; Guérois R; Modesti M; Sung P; Jasin M; Bernstein KA
    Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2202727119. PubMed ID: 36099300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex formation by the human RAD51C and XRCC3 recombination repair proteins.
    Masson JY; Stasiak AZ; Stasiak A; Benson FE; West SC
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8440-6. PubMed ID: 11459987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ATPase motif in RAD51D is required for resistance to DNA interstrand crosslinking agents and interaction with RAD51C.
    Gruver AM; Miller KA; Rajesh C; Smiraldo PG; Kaliyaperumal S; Balder R; Stiles KM; Albala JS; Pittman DL
    Mutagenesis; 2005 Nov; 20(6):433-40. PubMed ID: 16236763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparate requirements for the Walker A and B ATPase motifs of human RAD51D in homologous recombination.
    Wiese C; Hinz JM; Tebbs RS; Nham PB; Urbin SS; Collins DW; Thompson LH; Schild D
    Nucleic Acids Res; 2006; 34(9):2833-43. PubMed ID: 16717288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous-pairing activity of the human DNA-repair proteins Xrcc3.Rad51C.
    Kurumizaka H; Ikawa S; Nakada M; Eda K; Kagawa W; Takata M; Takeda S; Yokoyama S; Shibata T
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5538-43. PubMed ID: 11331762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization and identification of mouse Rad51d splice variants.
    Gruver AM; Yard BD; McInnes C; Rajesh C; Pittman DL
    BMC Mol Biol; 2009 Mar; 10():27. PubMed ID: 19327148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor.
    Greenhough LA; Liang CC; Belan O; Kunzelmann S; Maslen S; Rodrigo-Brenni MC; Anand R; Skehel M; Boulton SJ; West SC
    Nature; 2023 Jul; 619(7970):650-657. PubMed ID: 37344587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential and collaborative actions of Rad51 paralog proteins in cellular response to DNA damage.
    Yonetani Y; Hochegger H; Sonoda E; Shinya S; Yoshikawa H; Takeda S; Yamazoe M
    Nucleic Acids Res; 2005; 33(14):4544-52. PubMed ID: 16093548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
    Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R
    J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC3 ATPase activity is required for normal XRCC3-Rad51C complex dynamics and homologous recombination.
    Yamada NA; Hinz JM; Kopf VL; Segalle KD; Thompson LH
    J Biol Chem; 2004 May; 279(22):23250-4. PubMed ID: 15037616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Rad51C deficiency destabilizes XRCC3, impairs recombination, and radiosensitizes S/G2-phase cells.
    Lio YC; Schild D; Brenneman MA; Redpath JL; Chen DJ
    J Biol Chem; 2004 Oct; 279(40):42313-20. PubMed ID: 15292210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.